Alex Dasalla | Head, IR |
Joe Ciaffoni | CEO |
Paul Brannelly | CFO |
Scott Dreyer | Chief Commercial Officer |
David Amsellem | Piper Jaffray |
Greg Fraser | SunTrust |
Tian Sun | Needham & Company |
David Steinberg | Jefferies |
Tim Lugo | William Blair |
Brandon Folkes | Cantor Fitzgerald |
Kevin Kedra | G. Research |
Good day, and welcome to the Q2 2019 Collegium Pharmaceutical’s Earnings Conference Call.
I will now turn the call over to Alex Dasalla.
You may begin.
Welcome to the Collegium Pharmaceutical’s second quarter 2019 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium.